Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Recruiting2
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06244368Phase 2Recruiting
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Diffuse Large B-cell LymphomaPeripheral T Cell Lymphoma
PrincipalinvestigatorStart date: 2024-01-17
NCT06092606Phase 2Unknown
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
ArrhythmiaCancerDoxorubicin Adverse Reaction+2 more
PrincipalinvestigatorStart date: 2023-04-04
Relmacabtagene Autoleucel in Patients With LBCL
Large B-cell Lymphoma
PrincipalinvestigatorStart date: 2022-12-28
NCT05299424Phase 1/2Recruiting
A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
PrincipalinvestigatorStart date: 2022-08-09

Research Network

Collaboration Network

44 collaborators·82 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yufu Li

Henan Cancer Hospital

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Hui Zhou

Hunan Cancer Hospital

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Hesheng He

The First Affilaited Hospital of Wannan Medical College

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Xiaojia Wang

Zhejiang Cancer Hospital

Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Zhenchang Sun

The First Affiliated Hospital of Zhengzhou University

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Jiwei Liu

The First Affiliated Hospital of Dalian Medical University

Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Weili Zhao, PhD

Ruijin Hospital

Moderately Similar
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLarge B-cell LymphomaLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Xiaobo Wang

The Second Affiliated Hospital of Dalian Medical University

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Wanling Sun

Xuanwu Hospital, Beijing

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

HaiSheng、Chen Liu 、Huang

Hebei Medical University Fourth Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06244368Phase 2PrincipalInvestigator

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Diffuse Large B-cell LymphomaPeripheral T Cell Lymphoma
Recruiting
NCT06092606Phase 2PrincipalInvestigator

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

ArrhythmiaCancerDoxorubicin Adverse Reaction+2 more
Unknown
NCT06142175PrincipalInvestigator

Relmacabtagene Autoleucel in Patients With LBCL

Large B-cell Lymphoma
Unknown
NCT05299424Phase 1/2PrincipalInvestigator

A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Recruiting

All 4 trials loaded